Core Viewpoint - The acquisition of FYEO Europe B.V. by EuroEyes Netherlands Holding B.V. is expected to enhance the market position and competitiveness of the company in the refractive surgery sector, leveraging the growth potential in the Dutch market [1][2]. Group 1: Acquisition Details - EuroEyes Netherlands Holding B.V. has entered into a conditional sale agreement to acquire all issued shares of FYEO Europe B.V. for a total consideration of €131,766,173, adjusted for lockbox compensation and loss amounts [1]. - FYEO Europe B.V. is a private refractive surgery platform established in 2008 in the Netherlands, specializing in laser treatments and lens implants [1]. Group 2: Strategic Rationale - The board believes that the acquisition aligns with the company's strategic goals, as both entities are focused solely on refractive surgery and share a patient-centered approach [2]. - The target group is positioned to continue its growth trajectory through various favorable growth levers, including an expanding addressable market and advancements in refractive surgery technology [2]. - Post-acquisition, FYEO Europe B.V. will become a wholly-owned subsidiary, and its financial performance, assets, and liabilities will be consolidated into the company's financial statements [2].
德视佳(01846.HK)1.32亿欧元收购荷兰FYEO Europe 拓展欧洲屈光手术市场